The prospects and limitations of liquid biopsy utilization for clinical practice in Taiwan [0.03%]
液体活检在台湾临床实践中应用的前景和局限性
Huei-Ying Li,Chun-Chuan Chang,Yu-Hsuan Yang et al.
Huei-Ying Li et al.
Objective: Liquid biopsy is a promising, non-invasive diagnostic tool for cancer, offering rapid and cost-effective genomic analysis. It provides a less invasive alternative to traditional tissue biopsies, with potential ...
Liquid biopsy for lung cancer: A cross section on the diagnostic routine experience of a referral Italian institution [0.03%]
肺癌的液体活检：意大利一家转诊机构诊断常规经验的横断面分析
Caterina de Luca,Gianluca Russo,Mariantonia Nacchio et al.
Caterina de Luca et al.
Background: Lung cancer is the leading cause of cancer death worldwide. Over the last decade, molecular testing of a growing number of predictive biomarkers has become mandatory in the management of NSCLC patients. Howeve...
Rajib Dhar,Arikketh Devi
Rajib Dhar
Cancer is an unsolved health crisis worldwide. Extracellular vesicles (EVs) address this problem in a new way. In cancer, early detection is highly challenging, exosomes (a subpopulation of EVs, originating from endosomes) overcomes this li...
Liquid biopsy for assessment of RFS (recurrence-free survival) in NSCLC (non-small cell lung cancer) patients post-treatment through circulating tumour DNA detection: A meta-analysis [0.03%]
通过检测循环肿瘤DNA来评估非小细胞肺癌患者治疗后的无复发生存率的液体活检：一项荟萃分析
Urvi Zala,Rushi Patel,Viraj Panchal et al.
Urvi Zala et al.
Background: One of the main techniques for diagnosing lung cancer is still tissue biopsy. The more recent liquid biopsy technique includes the assessment of fragments of cfDNA, ctDNA, and CTCs, which are released by tumou...
Circulating epithelial cell as viral infection and tissue origin marker in patients with severe COVID-19 [0.03%]
重症COVID-19患者中循环上皮细胞作为病毒感染和组织起源的标志物
Valeria Denninghoff,María Del Carmen Garrido-Navas,María Del Pilar Molina-Vallejo et al.
Valeria Denninghoff et al.
Liquid biopsy (LB) is a minimally invasive procedure that detects biomarkers in body fluids for real-time monitoring of patients. This study developed a new LB approach to analyze Circulating Epithelial Cells (CECs) in Intensive Care Unit (...
Real-time assessment of HER2 status in circulating tumor cells of breast cancer patients: Methods of detection and clinical implications [0.03%]
乳腺癌患者循环肿瘤细胞中HER2状态的实时评估：检测方法及其临床意义
Eleonora Nicolò,Mara Serena Serafini,Laura Munoz-Arcos et al.
Eleonora Nicolò et al.
The human epidermal growth factor receptor 2 (HER2) plays a central role in breast cancer (BC). Therefore, it is critical to develop a method that can capture its spatial and temporal heterogeneity. Nowadays, therapeutic decisions for BC pa...
Liquid biopsy kinetics and detection of ERBB2 amplification/HER2-positivity in refractory hepatocellular carcinoma [0.03%]
液体活检动力学及耐药肝细胞癌中ERBB2扩增/HER2阳性的检测
Aaditya Srivant Geddam,Areeb Lutfi,Maaz Khan Afghan et al.
Aaditya Srivant Geddam et al.
Hepatocellular Carcinoma (HCC) is the most common primary liver carcinoma, accounting for 75-85% of all cases. For patients with advanced unresectable and/or metastatic HCC, treatment options primarily include immunotherapy combinations and...
"Plasma-first" approach for molecular genotyping in non-small cell lung cancer: A narrative review [0.03%]
非小细胞肺癌分子基因分型的“血浆优先”方法：一项叙述性回顾
Miguel García-Pardo,Natasha Leighl
Miguel García-Pardo
Molecular genotyping is essential for management of patients newly diagnosed with advanced non-small cell lung cancer (NSCLC). Plasma circulating tumor DNA (ctDNA) testing has emerged as a complement to tumor tissue genotyping for advanced ...
Harnessing liquid biopsies: Exosomes and ctDNA as minimally invasive biomarkers for precision cancer medicine [0.03%]
液体活检的临床应用：外泌体和ctDNA作为精准癌症医学中的一种微创型生物标志物
Oluwaseun Adebayo Bamodu,Chen-Chih Chung,Thomas R Pisanic nd
Oluwaseun Adebayo Bamodu
Liquid biopsies have emerged as groundbreaking tools for minimally invasive monitoring of cancer, encompassing the analysis of Cell-Free DNA (cfDNA), circulating tumor DNA (ctDNA) and exosomes. This paradigm shift offers an emerging approac...
Divya Mirgh,Anand Krishnan,Sukhamoy Gorai
Divya Mirgh